Published in Hepatology on May 01, 2010
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism (2010) 1.62
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol (2007) 1.50
Mobile phone exposure does not induce apoptosis on spermatogenesis in rats. Arch Med Res (2007) 1.43
Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments. Biomark Med (2010) 1.41
Apoptosis: why and how does it occur in biology? Cell Biochem Funct (2011) 1.29
Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract (2008) 1.08
The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct (2008) 1.02
Predictive value of the modified Early Warning Score in a Turkish emergency department. Eur J Emerg Med (2008) 1.01
Utilization of cytokeratin-based biomarkers for pharmacodynamic studies. Expert Rev Mol Diagn (2010) 1.00
Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro. Anticancer Drugs (2013) 0.96
Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention? Clin Biochem (2008) 0.95
Effects of extremely low-frequency magnetic field on caspase activities and oxidative stress values in rat brain. Biol Trace Elem Res (2010) 0.95
Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis. Arch Med Res (2009) 0.94
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food (2010) 0.94
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clin Biochem (2012) 0.93
Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease. Metab Syndr Relat Disord (2011) 0.92
Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem (2010) 0.92
Effects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal women. Maturitas (2005) 0.92
The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib. Tumour Biol (2012) 0.90
The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol (2011) 0.88
Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine (2012) 0.88
Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Med Sci Monit (2009) 0.87
Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. Scand J Clin Lab Invest (2010) 0.86
Palladium(II) saccharinate complexes with bis(2-pyridylmethyl)amine induce cell death by apoptosis in human breast cancer cells in vitro. Bioorg Med Chem (2013) 0.86
Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels. Hepatology (2009) 0.86
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem (2009) 0.85
Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology. Eur J Gastroenterol Hepatol (2012) 0.84
Liver disease and malnutrition. Best Pract Res Clin Gastroenterol (2013) 0.83
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol (2007) 0.82
Apoptosis-inducing effects of Morinda citrifolia L. and doxorubicin on the Ehrlich ascites tumor in Balb-c mice. Cell Biochem Funct (2009) 0.82
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res (2008) 0.82
Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. Eur J Gastroenterol Hepatol (2009) 0.82
Risk factors for low back pain and its relation with pain related disability and depression in a Turkish sample. Turk Neurosurg (2009) 0.82
Effect of mobile phone exposure on apoptotic glial cells and status of oxidative stress in rat brain. Electromagn Biol Med (2009) 0.81
Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B. Clin Chim Acta (2010) 0.81
Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients. Med Sci Monit (2009) 0.81
Higher serum nitrate levels are associated with poor survival in lung cancer patients. Clin Biochem (2006) 0.81
Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis. Eur J Gastroenterol Hepatol (2010) 0.81
Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease. Acta Cardiol (2008) 0.81
Nonalcoholic fatty liver disease: a nutritional approach. Metab Syndr Relat Disord (2012) 0.81
Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model? Fertil Steril (2007) 0.81
Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol (2007) 0.81
Investigation of fecal pancreatic elastase-1 levels in type 2 diabetic patients. Turk J Gastroenterol (2005) 0.81
Synthesis, structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro. Bioorg Med Chem (2013) 0.80
Can safe and long-term exposure to extremely low frequency (50 Hz) magnetic fields affect apoptosis, reproduction, and oxidative stress? Int J Radiat Biol (2013) 0.80
Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Dis Markers (2012) 0.80
Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy. Am J Nephrol (2011) 0.80
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease. Clin Chim Acta (2007) 0.80
Genotoxic, cytotoxic, and apoptotic effects of Hypogymnia physodes (L.) Nyl. on breast cancer cells. Environ Toxicol (2012) 0.80
A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments. Obes Surg (2008) 0.79
Cytotoxic activity of novel palladium-based compounds on leukemia cell lines. Anticancer Drugs (2015) 0.79
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter. Eur J Gastroenterol Hepatol (2016) 0.78
IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis. Tumour Biol (2015) 0.78
A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol (2014) 0.78
Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue. Hepatology (2009) 0.78
Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients. Metabolism (2009) 0.78
Promising anti-growth effects of palladium(II) saccharinate complex of terpyridine by inducing apoptosis on transformed fibroblasts in vitro. Bioorg Med Chem (2013) 0.78
Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease. Arch Med Res (2011) 0.78
Soluble cytokeratin 18 biomarkers may provide information on the type of cell death during early ischemia and reperfusion periods of liver transplantation. Clin Transplant (2010) 0.77
Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations? World J Gastroenterol (2009) 0.77
Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Scand J Gastroenterol (2009) 0.77
Can enhanced autophagy be associated with human longevity? Serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians. Rejuvenation Res (2014) 0.77
Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.77
Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study. Hepatogastroenterology (2004) 0.77
Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine. Cell Biochem Funct (2011) 0.77
Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. J Gastrointestin Liver Dis (2009) 0.77
Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis. Scand J Gastroenterol (2011) 0.77
The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond. Hepatology (2009) 0.77
trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies. Eur J Med Chem (2012) 0.76
Psychopathology in the context of obesity: the adiponectin hypothesis. Med Hypotheses (2007) 0.76
Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. Hepatogastroenterology (2012) 0.76
The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts. J Gastroenterol (2010) 0.76
Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency. Arch Med Res (2010) 0.76
Metformin, hepatitis C, and insulin resistance: sufficient evidence? Hepatology (2009) 0.76
Biochemical and proteomic analysis of a potential anticancer agent: Palladium(II) Saccharinate complex of terpyridine acting through double strand break formation. J Proteome Res (2014) 0.76
Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid. Atherosclerosis (2008) 0.76
Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.76
Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Am J Reprod Immunol (2009) 0.75
Liver enzymes and cardiovascular outcomes: a new research agenda. Hepatology (2010) 0.75
Is M65 really better than M30 as a biomarker of hepatic fibrosis? Hepatology (2012) 0.75
Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease. Hepatology (2010) 0.75
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Scand J Gastroenterol (2014) 0.75
Promising anticancer activity of a lichen, Parmelia sulcata Taylor, against breast cancer cell lines and genotoxic effect on human lymphocytes. Cytotechnology (2014) 0.75
Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease". J Pediatr Gastroenterol Nutr (2009) 0.75
Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats. Obes Surg (2011) 0.75
Unconjugated hyperbilirubinemia and liver histology in patients with non-alcoholic fatty liver disease. Clin Biochem (2012) 0.75
Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease. Clin Biochem (2008) 0.75
"Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18. Hepatology (2009) 0.75
Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.75
Concomitant colitis in a patient with Behcet's disease. J Gastrointestin Liver Dis (2008) 0.75
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study. Eur J Gastroenterol Hepatol (2017) 0.75
Coronary artery anomalies in patients with syndrome X. Anadolu Kardiyol Derg (2009) 0.75
Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia. Blood Coagul Fibrinolysis (2008) 0.75